CVE-2015-1057
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote...
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote attackers to inject arbitrary web script or HTML via the "Real Name" value.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote attackers to inject arbitrary web script or HTML via the "Real Name" value.
- Record
CVE-2015-1057- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote attackers to inject arbitrary web script or HTML via the "Real Name" value.
- Record
CVE-2015-1057- Updated
- 2026-11-02
EUVDEUVD-2015-1200 No score
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote attackers to inject arbitrary web script or HTML via the "Real Name" value.
- Record
EUVD-2015-1200- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-228c-q92x-7vr5 No score
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote...
Cross-site scripting (XSS) vulnerability in usersettings.php in e107 2.0.0 allows remote attackers to inject arbitrary web script or HTML via the "Real Name" value.
- Record
GHSA-228c-q92x-7vr5- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| Exploit-DB | e107 2 Bootstrap CMS - Cross-Site Scripting | 2015-01-03 |
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, Exploit-DB, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2015-1057 is a medium vulnerability (CVSS 4.3) in E107, published January 16, 2015. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 3.23%, the 88th percentile. No source names a fixed version.